Searched for
CIPLA TARGET PRICE
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- NLC India shares rally 18% to fresh record high after Q4 net profit skyrockets 189% YoYNLC India shares rose to a record high on Thursday after the company posted a 189% YoY surge in Q4 net profit to Rs 1,394 crore. Revenue ro...
- Cipla shares rally 8% despite 55% YoY slump in Q4 profit. Why Citi, Nuvama, other brokerages hiked targetCipla shares surged on Thursday, extending gains to nearly 11% in two sessions, after several brokerages turned bullish on the stock despit...
- Q4 earnings, crude oil, FII action among 8 factors to steer D-Street this weekIndian stock markets are set for a busy week. Key events like Q4 earnings announcements for many companies will influence trading. Foreign ...
- Pharma stocks buck market weakness as Dr Reddy's gainsPharma stocks showed strength on Thursday, defying market weakness. Dr Reddy's Laboratories saw significant gains, fueled by anticipation o...
- Cipla stock in focus after Q2 PAT beats estimates. Should you buy, sell or hold?Cipla's shares are in focus as the company reported a 15% YoY increase in consolidated net profit to Rs 1,303 crore for Q2 2024. Revenue ro...
- Cipla surges 10% with rise in price targetsThe average price target of the 28 analysts, whose ratings and price targets that have been compiled by Bloomberg, is ₹1,161. The stock clo...
- Cipla shares jump 9% after Q1 profit soars 45% YoY to Rs 996 crore. Should you buy, sell or hold?In morning session, the scrip was trading 8.5% higher at Rs 1.160 on BSE. Meanwhile, in the last one year, it has surged 19%.
- Buy Cipla, target price Rs 1,090: ICICI DirectICICI Direct has issued a buy call on Cipla with a target price of Rs 1090, higher than the current market price of Rs 914.45. Analysts pro...
- Hold Cipla, target price Rs 1080: Sharekhan by BNP ParibasCipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 77400.61 Crore) operating in Pharmaceuticals sector.
- Hold Cipla, target price Rs 1080: Sharekhan by BNP ParibasCipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 77566.07 Crore) operating in Pharmaceuticals sector.
- Buy Cipla, target price Rs 1260: Axis SecuritiesCipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 86522.68 Crore) operating in Pharmaceuticals sector.
- Buy Cipla, target price Rs 1230: Axis SecuritiesCipla key Products/Revenue Segments include Pharmaceuticals, Royalty Income, Other Operating Revenue, Export Incentives and Scrap for the y...
- Hold Cipla, target price Rs 1210: Sharekhan by BNP ParibasCipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 89460.16 Crore) operating in Pharmaceuticals sector.
- Brokerages see up to 20% upside in Cipla post Q1 results; time to buy?Cipla is on track to launch key products, such as gAdvair, gAbraxane, gRevlimid and three peptide products over FY23-24, it said, adding th...
- Analysts give a thumbs up to Cipla’s Q2 report card, see 30% upside in the stockJefferies was the most optimistic as it maintained its buy rating on the stock, and raised the target price to Rs 1,024 from Rs 914 earlier.
- Centrum cuts target price for CiplaCipla's revenues during Q2FY19 declined 2% YoY while the margin was down by 220 bps.
- Broker's call on Tata Motors, Cipla and GSK ConsumersMorgan Stanley upgraded Tata Motors to ‘Overweight’ on hopes of a cyclical recovery in profitability of Indian auto industry.
Load More
